LORRAINE CHILDS: Open Payments
NPI 1558498139 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,032 in 41 payments from 16 companies in 2025. Trend: 2023 $47 · 2024 $1,030 · 2025 $1,032
Food & beverage: $1,032
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $247 |
| BridgeBio Pharma, Inc. | 4 | $204 |
| Merck Sharp & Dohme LLC | 6 | $109 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $79 |
| PFIZER INC. | 3 | $71 |
| Esperion Therapeutics, Inc. | 3 | $70 |
| Boston Scientific Corporation | 2 | $42 |
| Inspire Medical Systems, Inc. | 1 | $37 |
| Amgen Inc. | 2 | $36 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
Products named: LEQVIO, Attruby, VERQUVO, Kerendia, VYNDAQEL, NEXLETOL, WATCHMAN FLX, INSPIRE.
Industry payments across FL — which companies pay providers there.
